Skip to main content
. 2017 Oct 28;32(2):97–104. doi: 10.1016/j.sjopt.2017.10.003

Fig. 5.

Fig. 5

(a) GROUP 1A before CXL. (b) GROUP 1A after CXL. (c) GRUP 1C before CXL+ Topical Tobramycin. (d) GRUP 1C after CXL+ Topical Tobramycin. (e) GRUP 2B 3 days after bacterial inoculation. (f) GRUP 2B 7 days after bacterial inoculation. (g) GRUP 2D before Topical vancomycin. (h) GRUP 2D after Topical vancomycin.